ROOT Stock Recent News

Jones Soda's Crossover Cannabis Brand Recognized in 2024 Benzinga Hemp Beverage Competition SEATTLE , Oct. 15, 2024 /PRNewswire/ -- Mary Jones, the crossover cannabis brand launched earlier this year by craft soda pioneer Jones Soda (CSE: JSDA, QTCQB: JSDA), swept the 'Best D9 THC-Infused Soda' category in the 2024 Benzinga Hemp Beverage Competition with a top award for its HD9 Root Beer and runner-up recognition for its HD9 Berry Lemonade. The awards were announced at last week's Benzinga Cannabis Capital Conference.

COLUMBUS, Ohio, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), the parent company of Root Insurance Company, today announced its plans to host a conference call to discuss financial results for the third quarter on Wednesday, October 30, 2024 at 5:00 p.m. Eastern Time. The company plans to release third quarter results in the investor relations section of its website at ir.joinroot.com after the close of the financial markets on Wednesday, October 30, 2024.

PHOENIX--(BUSINESS WIRE)--Sprouts Farmers Market, one of the largest and fastest-growing specialty retailers of fresh, natural and organic goods in the United States, is introducing its new exclusive line of more than 130 premium body care, personal care and home fragrance items – Real Root by Sprouts – to help its customers live a healthier lifestyle. From body and hair care items to spa-inspired soaps with natural fragrances from herbs and spices, Real Root by Sprouts products help people fee.

PALO ALTO, Calif. , Sept. 5, 2024 /PRNewswire/ --  First Connect Insurance Services , a digital platform designed to support independent agents by providing access to the nation's top carriers, today announced it is partnering with Root Insurance to offer API-powered quote and bind capabilities to independent insurance agents.

COLUMBUS, Ohio and WESTLAKE, Texas, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance Company, and Goosehead Insurance, Inc. (NASDAQ: GSHD), a rapidly growing independent personal lines insurance agency, today announced their technology integration partnership that is redefining the agent experience. This collaboration is a significant step toward a mutual goal to enhance the insurance process for agents and clients through cutting-edge technology.

RALEIGH, N.C.--(BUSINESS WIRE)--Vontier Corporation (NYSE: VNT), a leading global provider of critical technologies and solutions to connect, manage and scale the mobility ecosystem, announced today that Gilbarco Veeder-Root, a Vontier company and the worldwide technology leader for retail and commercial fueling operations, has secured two tenders worth a combined $59 million from Hindustan Petroleum Corporation Ltd. (HPCL). The tenders include $39 million for above-ground dispensers combined w.

Root, Inc. (ROOT) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $1.74. This compares to loss of $2.55 per share a year ago.

Root, Inc. (NASDAQ:ROOT ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Matt LaMalva - Head, IR Alex Timm - Co-Founder & CEO Megan Binkley - CFO Conference Call Participants Tommy McJoynt - KBW Yaron Kinar - Jefferies Elyse Greenspan - Wells Fargo Michael Ward - Citi Operator Greetings, and welcome to Root, Inc. Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.

COLUMBUS, Ohio, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), the parent company of Root Insurance Company, announced financial results for the quarter today. Root's second quarter financial results and management commentary can be found by accessing the shareholder letter posted to the company's investor relations website. An updated version of the company's investor presentation will also be available. Both can be found on ir.joinroot.com .

Regeneron is a powerhouse in drug discovery with a promising pipeline and innovative treatments. Revenues are stable with flagship drugs like Eylea providing a revenue cushion and Dupixent driving growth. The next-generation drugs in oncology and obesity are the next potential wave of growth, with even more exciting treatments following them.